TQ
Thibaut Quennesson
PhD Candidate
Ghent University
I'm working on
9 months ago
Design, synthesis and characterization of DXR inhibitors
About
My PhD takes place within the MepAnti ITN consortium. My main focus is the drug discovery of DXR inhibitors, the second enzyme of the MEP pathway, as anti-infectious agents to tackle antimicrobial resistance.
No publications yet
This innovator hasn't added publications yet. In the meantime, you might want to explore their patents, funding, and other profile details.
No funding yet
This innovator hasn't added funding yet. In the meantime, you might want to explore their publications, patents, and other profile details.
No patents yet
This innovator hasn't added patents yet. In the meantime, you might want to explore their publications, funding, and other profile details.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.